Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2025-12-24 @ 4:41 PM
NCT ID:
NCT02827266
Eligibility Criteria:
Inclusion Criteria:
* Type 1 or 2 diabetes
* Chronic renal failure (stage 2 to stage 5) defined by Glomerular Filtration Rate (GFR) less than (\<) 90 milliliter per minute per 1.73 square meter (mL/min/1.73 m\^2)
* Anemia related to chronic kidney disease and requiring treatment with erythropoiesis-stimulating agent (ESA) (2 values of hemoglobin less than or equal to 11 gram per deciliter \[g/dL\] during the 3 months prior to inclusion), and hemoglobin greater than 8 g/dL
Exclusion Criteria:
* Anemia due to a non-renal cause
* Poorly controlled hypertension
* Treatment with an erythropoiesis stimulating agent (ESA) within 3 months prior to the study
* Planned dialysis in next 3 months or organ transplant
* History of cancer except for basal cell cancer and cervical cancer in situ
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02827266
Study Brief:
Protocol Section:
NCT02827266